MediciNova, Inc.
MNOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 100% | – | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -988% | – | -252.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -857.2% | – | -251% |
| EPS Diluted | -0.23 | -0.17 | -0.29 | -0.21 |
| % Growth | -35.3% | 41.4% | -38.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |